Search
01/09/2021
Neurological complications in haematopoietic stem cell transplant patients
Turon-Vinas, E, Badell, I, Trabazo, M, Moron, G, Coca, E, Brio, S, Boronat, S. Neurological complications in haematopoietic stem cell transplant patients. REVISTA DE NEUROLOGIA. 2021; 73(5)DOI:10.33588/rn.7305.2021176. PMID:34328206. IF:1.235(Q4/10D).
01/08/2021
Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients
Ramirez, MJ, Pujol, R, Trujillo-Quintero, JP, Minguillon, J, Bogliolo, M, Rio, P, Navarro, S, Casado, JA, Badell, I, Carrasco, E, Balmana, J, Catala, A, Sevilla, J, Belendez, C, Argiles, B, Lopez, M, de Heredia, CD, Rao, G, Nicoletti, E, Schwartz, JD, Bueren, JA, Surralles, J. Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients. AMERICAN JOURNAL OF HEMATOLOGY. 2021; 96(8)DOI:10.1002/ajh.26234. PMID:33984160. IF:13.268(Q1/1D).
16/07/2021
Impact of COVID-19 on Spanish patients with Dravet syndrome and their caregivers: consequences of lockdown
Munoz, EC, Nabbout, R, Guerrero, SB, Herguedas, JL, Villanueva, V, Aibar, JA. Impact of COVID-19 on Spanish patients with Dravet syndrome and their caregivers: consequences of lockdown. REVISTA DE NEUROLOGIA. 2021; 73(2)DOI:10.33588/rn.7302.2021006. PMID:34254661. IF:1.235(Q4/10D).
01/07/2021
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment
Ariceta, G, Dixon, BP, Kim, SH, Kapur, G, Mauch, T, Ortiz, S, Vallee, M, Denker, AE, Kang, HG, Greenbaum, LA, Fraga, G, 312 Study Grp. The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment. KIDNEY INTERNATIONAL. 2021; 100(1)DOI:10.1016/j.kint.2020.10.046. PMID:33307104. IF:18.998(Q1/1D).